Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma

NCT00944801 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
63
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Regensburg

Collaborators